HSK disease cause greater HOAs

Article

Eyes with a history of herpes simplex keratitis (HSK) have significantly greater higher order aberrations (HOAs) than eyes with no past history of the disease, according to a paper.

Eyes with a history of herpes simplex keratitis (HSK) have significantly greater higher order aberrations (HOAs) than eyes with no past history of the disease, according to a paper.

Professor Marc Labetoulle et al., Service d'Ophtalmologie, Hopital Bicêtre, APHP, Université Paris, France, enrolled 15 patients with a history of recurrent unilateral HSK and normal Snellen visual acuity. The eyes were statically compared with normal fellow eyes (control group) and HOA, modulation transfer function (MTF) and Strehl ratio were measured using the OPD-SCAN II aberrometer. The measurements were performed at least 3 months after the last case of herpes.

The HSK group presented with significantly higher total HOA, trefoil and tetrafoil, compared to the control group. The HSK group also had significantly lower MTF and Strehl ratio compared to the control group. Eyes with corneal opacities in the HSK group tended to have greater optical aberrations than eyes with clear cornea.

There were greater HOAs in the eyes with a HSK history and this could explain some of the visual complaints of HSK. This includes decrease in contrast quality or reduced colour perception.

Please visit the British Journal of Ophthalmology to read the abstract.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Christine Curcio, PhD, of the University of Alabama at Birmingham Heersink School of Medicine, shares histology update and revised nomenclature for OCT with Sheryl Stevenson of the Eye Care Network and Ophthalmology Times
SriniVas R. Sadda, MD, FARVO, shares key points from his retina presentation at the International SPECTRALIS Symposium
Robert Sergott, MD, describes fluorescence lifetime imaging ophthalmoscopy (FLIO) and the International SPECTRALIS Symposium – And Beyond (ISS) in Heidelberg, Germany.
Rayaz Malik, MBChB, PhD, a professor of medicine at Weill Cornell Medicine - Qatar, spoke with Ophthalmology Times Europe about his presentation. It's titled "An eye on neurodegenerative diseases: Challenging the dogma" at the International SPECTRALIS Sympsoium. In conversation with Hattie Hayes, Ophthalmology Times Europe
Anat Loewenstein, MD, describes her presentation on remote imaging for age-related macular degeneration and geographic atrophy at the International SPECTRALIS Symposium, in conversation with Hattie Hayes of Ophthalmology Times Europe
Tyson Brunstetter, OD, PhD, a US Navy Aerospace Optometrist at the NASA Johnson Space Center in Houston, Texas, shares key takeaways from his keynote at the International SPECTRALIS Symposium (ISS)
Rayaz Malik, MBChB, PhD, shares his presentation, titled An eye on neurodegenerative diseases: Challenging the dogma, at this year's International SPECTRALIS Symposium
At the Retina World Congress, Siegfried Priglinger, MD, speaks about ensuring the best outcomes for preschool-aged patients
At the 2025 ASCRS meeting, Robert Ang, MD said small aperture IOLs can benefit all patients, especially those with complex corneas or who have undergone previous corneal refractive surgery
Viha Vig, MBChB graduate student at the University of Auckland, New Zealand, discusses her poster presentation on the relationship between mitochondiral disease, Alzheimer disease, and other types of dementia.
© 2025 MJH Life Sciences

All rights reserved.